Zymergen Inc.

NASDAQ: ZY · Real-Time Price · USD
2.43
0.00 (0.00%)
At close: Oct 18, 2022, 10:00 PM

Company Description

Zymergen Inc. design, develop, and commercialize microbes, molecules, and materials.

It offers an automation solution comprising reconfigurable automation carts, a modular hardware building blocks that allow for assembly of work cells customized for the particular needs of a lab; and automation control software, a cloud-based software used to control integrated automation systems.

It serves electronics, packaging, healthcare, agriculture, and other industries.

Zymergen Inc. was incorporated in 2013 and is based in Emeryville, California.

As of October 19, 2022, Zymergen Inc. operates as a subsidiary of Ginkgo Bioworks Holdings, Inc.

Zymergen Inc.
Zymergen Inc. logo
Country United States
IPO Date Apr 22, 2021
Industry Chemicals - Specialty
Sector Basic Materials
Employees 502
CEO Joshua J. Hoffmann

Contact Details

Address:
5980 Horton Street
EmeryVille, California
United States
Website https://www.zymergen.com

Stock Details

Ticker Symbol ZY
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001645842
CUSIP Number 98985X100
ISIN Number US98985X1000
Employer ID 46-2942439
SIC Code 8731

Key Executives

Name Position
Dmitriy Ryaboy Chief Technology Officer
Enakshi Singh Chief Financial Officer
Devin Scannell Senior Vice President of Drug Discovery
Duane Valz J.D. Sec.
Lincoln Germain Chief Commercial Officer
Mike Dulin Director of Communications
Mina Kim Corporation Sec.
Subodh S. Deshmukh Chief Devel. Officer

Latest SEC Filings

Date Type Title
Oct 31, 2022 15-12G Filing
Oct 21, 2022 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Oct 21, 2022 4 Filing
Oct 19, 2022 4 Filing
Oct 19, 2022 4 Filing
Oct 19, 2022 4 Filing
Oct 19, 2022 4 Filing
Oct 19, 2022 4 Filing
Oct 19, 2022 4 Filing
Oct 19, 2022 4 Filing